Precision BioSciences, Inc. (DTIL) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 53.36M |
| Enterprise Value | -28.66M |
| P/E Ratio | -3.17 |
| PEG Ratio | -0.02 |
| Price/Sales Ratio | 2.52 |
| Price/Book Ratio | 5.05 |
| Enterprise/Revenue | 1.23 |
| Enterprise/EBITDA | -1.11 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -1.17 |
| Operating Margin | -0.81 |
| Return On Assets | -0.42 |
| Return On Equity | -0.92 |
| Revenue | 34.26M |
| Revenue/Share | 1.74 |
| Gross Profit | 34.26M |
| EBITDA | -42.43M |
| Net Income | -45.72M |
| Diluted EPS | -3.56 |
| Total Cash | 87.55M |
| Total Cash/Share | 3.39 |
| Total Debt | 28.1M |
| Total Debt/Equity | 0.62 |
| Current Ratio | 12.82 |
| Book Value Per Share | 1.75 |
| 52-Week Change | 78.43 |
| 52-Week High | 9.62 |
| 52-Week Low | 3.53 |
| Moving Average 50 Days | 7.59 |
| Moving Average 200 Days | 6.06 |
| Average Volume | 442,270 |
| Shares Outstanding | 12.83M |
| % Held by Institutions | 65.56 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:30 |
| Last Split Date | February 14, 2024 |